755219

216364

AVIENCE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AVIENCE BIOMEDICALS LTD Share Price Today

AVIENCE BIOMEDICALS LTD made its stock market debut on 25 June 2026 and is currently trading at ₹394.25, down by ₹20.7 from the previous close. The stock touched an intraday high of ₹394.25 and a low of ₹394.25 during the latest trading session.

AVIENCE BIOMEDICALS LTD performance

Today’s low Today’s high
₹ 394.25 ₹ 394.25
₹ 394.25
52 week low 52 week high
₹ 394.25 ₹ 414.95
₹ 394.25
Open Price ₹ 394.25
Prev. Close ₹ 414.95
Volume (Shares) 52200.00
Total traded value ₹ 205.79
Upper Circuit ₹ 435.65
Lower Circuit ₹ 394.25
info

AVIENCE BIOMEDICALS LTD fundamentals


  • Market cap (Cr) 216.20
  • P/E Ratio (TTM) 45.50
  • Beta 0.00
  • Book Value / share 144.81
  • Return on equity 37.79%
  • EPS (TTM) 9.21
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

AVIENCE BIOMEDICALS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 28.89
Operating Expense 22.59
Net Profit 5.00
Net Profit Margin (%) 17.30
Earnings Per Share (EPS) 13.19
EBITDA 8.23
Effective Tax Rate (%) 27.07
Particulars MAR 2024 (Values in Cr)
Revenue 16.26
Operating Expense 13.89
Net Profit 2.00
Net Profit Margin (%) 12.30
Earnings Per Share (EPS) 6.09
EBITDA 3.60
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 10.92
Operating Expense 9.96
Net Profit 0.78
Net Profit Margin (%) 7.14
Earnings Per Share (EPS) 3.77
EBITDA 1.44
Effective Tax Rate (%) 18.75
Particulars MAR 2022 (Values in Cr)
Revenue 10.15
Operating Expense 9.19
Net Profit 0.71
Net Profit Margin (%) 6.99
Earnings Per Share (EPS) 6.86
EBITDA 1.22
Effective Tax Rate (%) 26.04
Particulars MAR 2025 (Values in Cr)
Book Value / Share 56.21
ROE % 49.17
ROCE % 33.68
Total Debt to Total Equity 1.29
EBITDA Margin 26.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.96
ROE % 34.73
ROCE % 18.41
Total Debt to Total Equity 2.43
EBITDA Margin 19.16
Particulars MAR 2025 (Values in Cr)
Book Value / Share 50.62
ROE % 37.79
ROCE % 31.25
Total Debt to Total Equity 0.81
EBITDA Margin 28.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.48
ROE % 39.49
ROCE % 31.08
Total Debt to Total Equity 1.03
EBITDA Margin 22.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.41
ROE % 22.74
ROCE % 20.45
Total Debt to Total Equity 0.75
EBITDA Margin 13.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.73
ROE % 25.81
ROCE % 21.36
Total Debt to Total Equity 0.89
EBITDA Margin 12.02
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.93
Total Assets 56.48
Total Liabilities 56.48
Total Equity 22.65
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 12.56
Return on Capital (%) 15.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.35
Total Assets 34.63
Total Liabilities 34.63
Total Equity 6.22
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.23
Return on Capital (%) 10.11
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.75
Total Assets 43.56
Total Liabilities 43.56
Total Equity 20.40
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.48
Return on Capital (%) 14.65
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 25.61
Total Liabilities 25.61
Total Equity 6.06
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.81
Return on Capital (%) 14.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 10.02
Total Liabilities 10.02
Total Equity 4.07
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.80
Return on Capital (%) 11.62
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 6.09
Total Liabilities 6.09
Total Equity 2.79
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.78
Return on Capital (%) 13.6
Particulars MAR 2025 (Values in Cr)
Net Income 9.76
Cash from Operations 4.18
Cash from Investing -9.54
Cash from Financing 10.20
Net change in Cash 4.05
Free Cash Flow 13.48
Particulars MAR 2024 (Values in Cr)
Net Income 3.02
Cash from Operations 1.19
Cash from Investing -4.02
Cash from Financing 2.93
Net change in Cash -0.07
Free Cash Flow 5.07
Particulars MAR 2025 (Values in Cr)
Net Income 6.86
Cash from Operations 3.79
Cash from Investing -8.16
Cash from Financing 9.05
Net change in Cash 4.03
Free Cash Flow 11.71
Particulars MAR 2024 (Values in Cr)
Net Income 2.74
Cash from Operations 0.34
Cash from Investing -4.12
Cash from Financing 3.80
Net change in Cash -0.09
Free Cash Flow 4.32
Particulars MAR 2023 (Values in Cr)
Net Income 0.96
Cash from Operations 1.91
Cash from Investing -1.93
Cash from Financing 0.43
Net change in Cash 0.23
Free Cash Flow 3.60
Particulars MAR 2022 (Values in Cr)
Net Income 0.96
Cash from Operations -1.80
Cash from Investing -0.88
Cash from Financing 2.78
Net change in Cash -0.06
Free Cash Flow -0.93
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8593.25 63.16 13.04 123557.75 6680.00 8692.00
FORTIS MALAR HOSPITALS LIMITED 52.42 23.72 2.86 98.24 40.75 76.00
SHREE PACETRONIX LTD. 130.05 15.52 2.73 48.76 66.10 283.15
TRANSGENE BIOTEK LTD. 3.11 0.00 2.81 23.56 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8593.25 82.30 12.40 123557.75 6680.00 8692.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.60 0.00 -9.63 29.58 30.30 57.48
KOVAI MEDICAL CENTER & HO 6020.65 26.94 4.99 6586.59 5010.00 6725.00

AVIENCE BIOMEDICALS LTD shareholding pattern

Holding
23.26%
64.59%
3.06%
9.08%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

AVIENCE BIOMEDICALS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
394.25 -4.98 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 414.90
  • 26 Days 414.90
  • 10 Days 414.90
  • 50 Days 414.90
  • 12 Days 414.90
  • 100 Days 414.90
  • 20 Days 414.90
  • 200 Days 414.90
0.00 PIVOT
First Support 0.00 First Resistance 0.00 Second Support 0.00 Second Resistance 0.00 Third Support 0.00 Third Resistance 0.00
RSI 0.00 ADX 0.00 MACD 0.00 Williams % R 0.00 Commodity Channel Index (CCI) 0.00
Date 2026-06-25 Week 726000.00 Same Day 726000.00 Month 726000.00
1 Year 0.0 3 Year 0.0
Over 1 Month
0.00% down
Over 1 Year
0.00% down
Over 3 Months
0.00% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

AVIENCE BIOMEDICALS LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Avience Biomedicals Ltd?

Answer Field

Avience Biomedicals Ltd share price is for NSE ₹ 394.25 & for BSE ₹ 0.00 as on Jun 29 2026 10:03 AM.

What is the Market Cap of Avience Biomedicals Ltd Share?

Answer Field

The market cap of Avience Biomedicals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 29 2026 10:03 AM.

What is the 52 Week High and Low of Avience Biomedicals Ltd?

Answer Field

The 52 Week High and Low of Avience Biomedicals Ltd for NSE is ₹ 414.95 and ₹ 394.25 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Avience Biomedicals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Avience Biomedicals Ltd Share?

Answer Field

As on Jun 29 2026 10:03 AM the price-to-earnings (PE) ratio for Avience Biomedicals Ltd share is 45.50.

What is the PB ratio of Avience Biomedicals Ltd Share?

Answer Field

As on Jun 29 2026 10:03 AM, the price-to-book (PB) ratio for Avience Biomedicals Ltd share is 144.81.

How to Buy Avience Biomedicals Ltd Share?

Answer Field

You can trade in Avience Biomedicals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Avience Biomedicals Ltd Share on Bajaj Broking App?

Answer Field

To buy Avience Biomedicals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Avience Biomedicals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|